Drug Shortage Report for BIVALIRUDIN INJECTION

Last updated on 2023-02-27 History
Report ID 171467
Drug Identification Number 02505517
Brand name BIVALIRUDIN INJECTION
Common or Proper name Bivalirudin infection
Company Name AVIR PHARMA INC.
Market Status MARKETED
Active Ingredient(s) BIVALIRUDIN
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size vials
ATC code B01AE
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2022-10-11
Actual start date 2022-10-11
Estimated end date 2023-02-24
Actual end date 2023-02-24
Shortage status Resolved
Updated date 2023-02-27
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 660 BOULEVARD INDUSTRIEL
BLAINVILLE, QUEBEC
CANADA J7C 3V4
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2023-02-27 French Compare
v12 2023-02-27 English Compare
v11 2023-02-17 French Compare
v10 2023-02-17 English Compare
v9 2023-02-03 French Compare
v8 2023-02-03 English Compare
v7 2023-01-03 French Compare
v6 2023-01-03 English Compare
v5 2022-11-17 French Compare
v4 2022-11-17 English Compare
v3 2022-10-12 English Compare
v2 2022-10-11 French Compare
v1 2022-10-11 English Compare

Showing 1 to 13 of 13